Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate

Journal of Urology

Volumn 156, Issue 5, 1996, Pages 1685-1690

  Presti Jr , Joseph C ^a   Hovey, Regina ^a   Carroll, Peter R ^a   Shinohara, Katsuto ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

diagnosis; prostate specific antigen; prostatic neoplasms; ultrasonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CARCINOMA; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0029853477     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65483-1     Document Type: Article

References (10)

1. Benson, M. C., Whang, I. S., Olsson, C. A., McMahon, D. J. and Cooner, W. H.: The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J. Urol., part 2, 147: 817, 1992.
2. Benson, M. C., Whang, I. S., Pantuck, A., Ring, K., Kaplan, S. A., Olsson, C. A. and Cooner, W. H.: Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J. Urol., part 2, 147: 815, 1992.
3. Jaeschke, R., Guyatt, G. H. and Sackett, D. L.: User's guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA, 271: 703, 1994.
4. Brawer, M. K., Aramburu, E. A. G., Chen, G. L., Preston, S. D. and Ellis, W. J.: The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma. J. Urol., 150: 369, 1993.
5. Rommel, F. M., Agusta, V. E., Breslin, J. A., Huffnagle, H. W., Pohl, C. E., Sieber, P. R. and Stahl, C. A.: The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice. J. Urol., 151: 88, 1994.
6. Bazinet, M., Meshref, A. W., Trudel, C., Aronson, S., Peloquin, F., Nachabe, M., Begin, L. R. and Elhilali, M. M.: Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma. Urology, 43: 44, 1994.
7. Shinohara, K., Wolf, J. S., Jr., Narayan, P. and Carroll, P. R.: Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications. J. Urol., 152: 120, 1994.
8. Catalona, W. J., Richie, J. P., deKernion, J. B., Ahmann, F. R.: Ratliff, T. L., Dalkin, B. L., Kavoussi, L. R., MacFarlane, M. T. and Southwick, P. C.: Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J. Urol., 152: 2031, 1994.
9. Cookson, M. S., Floyd, M. K., Ball, T. P., Jr., Miller, E. K. and Sarosdy, M. F.: The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels. J. Urol., 154: 1070, 1995.
10. Fagan, T. J.: Nomogram for Bayes's theorem. Letter to the Editor. New Engl. J. Med., 293: 257, 1975.